معرفی
Caroline Hendry is a Researcher and Scientific Director in the Genetics Department at Yale School of Medicine. She serves as Advisor to the Chair of Genetics and Director of the Office for Strategic Research Development, focusing on advancing rare disease research, population health screening, and gene-based therapies. Her work emphasizes cross-functional research collaboration and operational efficiency in both basic and clinical research domains.
Education: BSc (Honors) in Genetics from the University of Queensland (2006), PhD in Developmental Genetics from the University of Queensland's Institute for Molecular Bioscience (2010), and postdoctoral training in molecular reprogramming at Mount Sinai School of Medicine (2012). Currently completing an MBA at Yale School of Management, specializing in healthcare leadership.
Research Interests: Her work centers on rare disease discovery, innovative genetic technologies (including CRISPR applications), AI-driven clinical diagnostics, and value-based healthcare models. She actively develops tools for population health screening and explores AI's role in optimizing clinical evaluation processes.
Professional Contributions: Co-Investigator on major NIH grants in clinical-translational research. Leads strategic initiatives in rare disease research and has published extensively on topics ranging from stem cell migration to epigenetic reprogramming mechanisms. Active in academic leadership, advocating for complementary scientific director roles to enhance institutional research capacity.
Grants & Administration: Oversees strategic research development at Yale Genetics, including portfolio planning and operational systems improvement. Engaged in initiatives to advance gene therapy and IND-enabling research for cell-based treatments.
